To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CareDx by 22,860 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 3.41% of the total position.
      126Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 41,701 shares, the number of shares held decreased 1.36% compared to the previous period and now represents 2.35% of the total position.
      32Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 81,488 shares, the number of shares held increased 4.2% compared to the previous period and now represents 3.04% of the total position.
      70Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Amgen by 477 shares, the number of shares held decreased 1.1% compared to the previous period and now represents 1.22% of the total position.
      16Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 23,823 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 5.91% of the total position.
      63Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veeva by 432 shares, the number of shares held decreased 1.09% compared to the previous period and now represents 0.75% of the total position.
      28Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 117,702 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 1.72% of the total position.
      6.76KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 279 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 0.97% of the total position.
      8Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 36,468 shares, the number of shares held decreased 7.64% compared to the previous period and now represents 3% of the total position.
      28Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 53,604 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 1.5% of the total position.
      8Comment
      Report
       
       
       
       

      Most Discussed